Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study-Reference-Cited by-同舟云学术

Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study

Published:2020-01 Issue:1 Volume:13 Page:100095
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Riccio Anna Maria,Mauri Pierluigi,De Ferrari Laura,Rossi Rossana,Di Silvestre Dario,Bartezaghi Marta,Saccheri Fabiana,Canonica Giorgio Walter

Funder

Novartis Farma S.p.A

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference28 articles.

1. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA),2018

2. The Global Asthma Report 2018,2018

3. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010;de Marco;Eur Respir J,2012

4. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE;Humbert;Allergy,2005

5. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma;Ayres;Allergy,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Roles of Galectin-3 in Pulmonary Diseases;Lung;2024-06-08

2. The Role of Galectins in Asthma Pathophysiology: A Comprehensive Review;Current Issues in Molecular Biology;2024-05-03

3. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons;Cells;2024-02-23

4. Promising treatment biomarkers in asthma;Frontiers in Drug Safety and Regulation;2023-11-07

5. Real-world super-response to biologics in severe asthma: A French monocentric retrospective cohort study;Respiratory Medicine and Research;2023-11